HIGHLIGHTING
TB-RICC IN 2024
Recap 2024
This past year has been an exciting time for RePORT International and TB-RICC! Our readership has grown by 80 percent in 2024, and we are honored to have you join us for this journey. Please check out this special December edition of our newsletter that showcases a collection of the monthly articles from 2024, contributed by Daphne Martin, Rajita Bhavaraju, and many of our esteemed partners. We look forward to sharing more with you next year!
SA – Where Innovation Emanates
Featuring RePORT South Africa: here Innovation Emanates
RePORT South Africa (SA) III is a collaborative research network, comprised of 14 research groups from seven South African and four US institutions, spearheading innovative research in the field of tuberculosis (TB) biomarkers. Led by eight clinical research sites and five analytical laboratories, the network’s structure is robust, with each institution playing a significant role in contributing to a wealth of TB biomarker knowledge and expertise.
Collaborative Research Innovation
Featuring RePORT India: Fostering Collaborative Research and Innovation in TB
Held from April 2-5, the 13th RePORT India Annual Meeting at the National Institute of Immunology (NII) in New Delhi was highlighted in this article. Delegates from the 13th RePORT India Annual Meeting Organized under the auspices of the Department of Biotechnology (DBT), Government of India, and the NIAID.
Ending TB
Ending TBEnding TB: The Critical Role of Determinants
Is TB Care Humanistic?
Is TB Care Humanistic?Is Tuberculosis Care Humanistic? What the Latest Evidence Reveals
Global Fight Against TB
Reflections on World TB Day: Voices from the Global Fight Against TB
In observance of the annual March 24 World TB Day, we asked members of our network to reflect on where we are in the fight against TB and to share their thoughts on the role of RePORT International in TB prevention and care worldwide and in the fight to end tuberculosis.
Innovations in TB Healthcare
Featuring RePORT Uganda: An Interview with Moses Joloba
In this interview with Ms. Daphne Martin, TB-RICC Program Manager, Dr. Moses Joloba, a renowned scientist in Uganda’s medical and research community and a RePORT International Principal Investigator, shared insights into his remarkable journey in the field of tuberculosis research.
Interview with Sudha Srinivasan
An Interview with Sudha Srinivasan: The Origin of RePORT
This is a summary of a conversation with Dr. Sudha Srinivasan, former Program Officer at the TB Clinical Research Branch at the Division of AIDS at the National Institutes of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health. In this role, Dr. Srinivasan was the Project Officer for RePORT International and played a key role in managing and the evolution of RePORT International.
What's new
Update on Biomarkers Study
update on biomarkers studyAnalysis of Host Biomarkers Associatedwith Adverse TB Treatment Outcomes Across RePORT International SitesAnalysis of Host Biomarkers Associatedwith Adverse TB Treatment Outcomes Across RePORT International Sites Sheetal Verma
RiCC Leadership Group
RICC International leadershipCopenhagen | November 18, 2025Meeting Highlights Copenhagen | November 18, 2025 The RePORT International Leadership Group met in Copenhagen on November 18 to review ongoing research activities and strategic priorities across the...
Data Operations Meeting
Data operations meetingOperationalizing Data Sharing, Learning, and PlanningOperationalizing Data Sharing, Learning, and Planning throughout RePORT International RePORT International’s Data Core hosted its Data Operations meeting on December 8, 2025, with...